NDC 19515-906
Flulaval Quadrivalent 2019/2020
Influenza Virus Vaccine
Flulaval Quadrivalent 2019/2020 is a Intramuscular Suspension in the Vaccine category. It is labeled and distributed by Id Biomedical Corporation Of Quebec. The primary component is Influenza A Virus A/brisbane/02/2018 Ivr-190 (h1n1) Antigen (uv, Formaldehyde Inactivated); Influenza A Virus A/kansas/14/2017 X-327 (h3n2) Antigen (uv, Formaldehyde Inactivated); Influenza B Virus B/phuket/3073/2013 Antigen (uv, Formaldehyde Inactivated); Influenza B Virus B/maryland/15/2016 Bx-69a Antigen (uv, Formaldehyde Inactivated).
| Product ID | 19515-906_2a9a9563-8797-4c1f-acbf-d2c4ef974e87 |
| NDC | 19515-906 |
| Product Type | Vaccine |
| Proprietary Name | Flulaval Quadrivalent 2019/2020 |
| Generic Name | Influenza Virus Vaccine |
| Dosage Form | Suspension |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2019-07-02 |
| Marketing End Date | 2020-06-30 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125163 |
| Labeler Name | ID Biomedical Corporation of Quebec |
| Substance Name | INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/MARYLAND/15/2016 BX-69A ANTIGEN (UV, FORMALDEHYDE INACTIVATED) |
| Active Ingredient Strength | 15 ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL |
| NDC Exclude Flag | N |